FLSM
ERAS icon

Frazier Life Sciences Management’s Erasca ERAS Stock Holding History

Frazier Life Sciences Management’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399M Buy
24,675,188
+1,945,752
+9% +$23M 10.27% 3
2025
Q4 		$84.6M Hold
22,729,436
– – 2.27% 11
2025
Q3 		$49.6M Hold
22,729,436
– – 1.48% 16
2025
Q2 		$28.9M Buy
22,729,436
+153,585
+0.7% +$206K 1.15% 19
2025
Q1 		$30.9M Buy
22,575,851
+3,184,164
+16% +$5.46M 1.41% 19
2024
Q4 		$48.7M Hold
19,391,687
– – 2.02% 12
2024
Q3 		$52.9M Buy
19,391,687
+3,175,471
+20% +$8.94M 2.12% 14
2024
Q2 		$38.3M Buy
+16,216,216
New +$35M 1.79% 17

Other funds holding ERAS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Frazier Life Sciences Management's ERAS Position: Q1 2026 in Review

Frazier Life Sciences Management increased its Erasca (ERAS) stake by 8.6% in Q1 2026, buying an estimated $23M and bringing the position to 24,675,188 shares worth $399M. The position accounts for 10.27% of the portfolio, ranked #3.

Frazier Life Sciences Management first reported a position in ERAS in Q2 2024 and has held it in 8 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Frazier Life Sciences Management held 24,675,188 shares of Erasca worth $399M as of Q1 2026.
  • Frazier Life Sciences Management bought 1,945,752 Erasca shares in Q1 2026, an estimated $23M.
  • Erasca made up 10.27% of Frazier Life Sciences Management's portfolio in Q1 2026, its #3 holding.
  • Frazier Life Sciences Management first reported a position in Erasca in Q2 2024 and has held it in 8 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Frazier Life Sciences Management's 13F filing for Q1 2026, filed 15 May 2026.